Feature

Bacterial Pseudaminic Acid Emerges as an Immune Target

Glycoproteomic mapping reveals pseudaminic acid as a shared feature across pathogenic bacteria 

  • By

  • February 18, 2026

  • 2 min

Share

  • 1

    Study published in Nature Chemical Biology.

  • 2

    Focus on pseudaminic acid antibodies.

  • 3

    Developed monoclonal antibodies using synthetic chemistry.

  • 4

    Enhanced phagocytosis in drug-resistant pathogens.

  • 5

    Proven effective in mouse models.

  • 6

    Potential for new passive immunotherapies.

  • 7

    Aimed to combat Acinetobacter baumannii.

Original Source(s)

Bacterial Pseudaminic Acid Emerges as an Immune Target

Glycoproteomic mapping reveals pseudaminic acid as a shared feature across pathogenic bacteria 

  • February 18, 2026

  • 2 min

Related Content

Conjugative CRISPR System Cuts Resistance

Mobile gene drive-like platform spreads between bacteria and reduces ampicillin resistance by up to 5 logs while enabling cassette reversal

Defining Appropriate Antibiotics

Scoping review argues for clearer definitions of appropriate antibiotic therapy in clinical research

The 5-Hour Sepsis Test: No Cultures Required

Rapid culture-free test results are consistent with the gold standard for sepsis detection